Merck and United jump while Signet and SuperValu fall

The company said that regulators will perform a fast review of an application that could boost sales of its cancer drug Keytruda.

The robotic surgical system maker forecast solid revenue in the fourth quarter thanks to strong sales of instruments and accessories.

The grocery store operator announced a weak third-quarter profit, partly because of falling food prices.